• Research Blog

    This blog has been compiled by 5 trainee paediatric gastroenterologists who are all actively involved in research into paediatric inflammatory bowel disease:

    • Dr Fiona Cameron, University of Edinburgh (CICRA fellow)
    • Dr Ed Giles, Queen Mary University of London (CICRA fellow)
    • Dr Paul Henderson, University of Edinburgh
    • Dr Tony Wiskin, University of Southampton (ex-CICRA fellow)
    • Tracy Coelho, University of Southampton

    Links are provided to the free abstracts of each article, but full access may require a fee for those without institutional privileges.

    Many thanks to Richard Hansen who has put together this blog for the last few years. He has recently started as a consultant in Glasgow so we send him our congratulations and wish him good luck in his new job. We welcome Tracy Coelho – a new CICRA fellow to the blog. He has started a PhD in Southampton to investigate how defects identified by genetic screening affect immune function.

    Latest Blog

    05.13.15 Viruses in IBD – the new front-line in microbiota research?

    Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease, Norman J, Handley S, et al, Cell 160, 1–14, 2015 http://www.cell.com/abstract/S0092-8674(15)00003-3 (It has a picture that describes its findings) There has been a great deal of interest and research into the field of the microbiota in IBD in recent years, often discussed in this blog. […]

    A new drug for resistant Crohn’s disease
    Exercise and chance of disease flare up
    Does a specific diet work to manage Crohn’s Disease?
    A breath is all it takes?
    The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
    Vitamin B12 Deficiency in Inflammatory Bowel disease: Prevalence, Risk Factors, Evaluation, and Management
    Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease strictures
    Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease A Randomized Clinical Trial
    Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation